Last reviewed · How we verify
Malignant tumor of colon
Approved treatments
- Carac · Spectrum Pharms
- Erbitux · Imclone
Erbitux works by binding to the Epidermal Growth Factor Receptor (EGFR) on cancer cells, blocking the receptor's ability to stimulate cell growth and division. - Mifurol
Mifurol works by inhibiting the enzyme acid ceramidase, which plays a role in the development and progression of cancer cells. - Carac · Extrovis
- Lonsurf · Taiho Oncology Inc
Lonsurf works by inhibiting the enzyme thymidine phosphorylase, which is involved in the breakdown of certain cancer medications. - Erbitux · Hellenic Oncology Research Group
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of colon patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of colon treatment landscape brief
- Malignant tumor of colon treatment updates RSS
Frequently asked questions about Malignant tumor of colon
What drugs treat Malignant tumor of colon?
Tracked treatments include Carac, Erbitux, Mifurol, Lonsurf.
What is the treatment for Malignant tumor of colon?
Standard treatment for Malignant tumor of colon includes Carac, Erbitux, Mifurol, Lonsurf. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant tumor of colon patent cliff · Malignant tumor of colon CI report
- Treatment: Carac · Spectrum Pharms
- Treatment: Erbitux · Imclone
- Treatment: Mifurol
- Treatment: Carac · Extrovis
- Treatment: Lonsurf · Taiho Oncology Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing